Profiles of pregabalin and gabapentin abuse by postmortem toxicology

Forensic Science International

Volumn 241, Issue , 2014, Pages 1-6

  Häkkinen, Margareeta ^a   Vuori, Erkki ^a   Kalso, Eija ^a   Gergov, Merja ^a   Ojanperä, Ilkka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Blood drug concentration; Drug abuse; Fatal poisoning; Gabapentin; Postmortem toxicology; Pregabalin

Indexed keywords

GABAPENTIN; NARCOTIC ANALGESIC AGENT; PREGABALIN; 4 AMINOBUTYRIC ACID; AMINE; ANTICONVULSIVE AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; NARCOTIC AGENT;

ADULT; AGED; ARTICLE; AUTOPSY; CONTROLLED STUDY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG INTOXICATION; FATALITY; FEMALE; FINLAND; FORENSIC TOXICOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SUICIDE ATTEMPT; VERY ELDERLY; YOUNG ADULT; ADDICTION; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; EPIDEMIOLOGY; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MORTALITY; POSTMORTEM CHANGE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINES; ANTICONVULSANTS; CHROMATOGRAPHY, LIQUID; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; FINLAND; FORENSIC TOXICOLOGY; GAMMA-AMINOBUTYRIC ACID; HUMANS; LIMIT OF DETECTION; MALE; MASS SPECTROMETRY; MIDDLE AGED; NARCOTICS; POSTMORTEM CHANGES; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84900507370     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2014.04.028     Document Type: Article

References (33)

1. Bandelow B., Wedekind D., Leon T. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention. Expert Rev. Neurother. 2007, 7:769-781.
2. Schwan S., Sundström A., Stjernberg E., Hallberg E., Hallberg P. A signal for an abuse liability for pregabalin - results from the Swedish spontaneous adverse drug reaction reporting system. Eur. J. Clin. Pharmacol. 2010, 66:947-953.
3. Gahr M., Freudenmann R.W., Hiemke C., Kölle M.A., Schönfeldt-Lecuona C. Pregabalin abuse and dependence in Germany: results from a database query. Eur. J. Clin. Pharmacol. 2013, 69:1335-1342.
4. Lottner-Nau S., Övgüer B., Paul L.D., Graw M., Sachs H., Roider G. Abuse of pregabalin - results of the postmortem toxicology from 2010 to 2012. Toxichem. Krimtech. 2013, 80:339-342.
5. Nomoto M., Tsujii T., Kyaw W., Nishikawa N., Iwaki H., Nagai M. PP033 - Effects of pregabalin on driving. Clin. Ther. 2013, 35:e28.
6. Kriikku P., Wilhelm L., Rintatalo J., Hurme J., Kramer J. OA5 - Pregabalin levels in apprehended drivers. The 51st Annual Meeting of the International Association of Forensic Toxicologists (TIAFT) 2013.
7. Schifano F., D'Offizi S., Piccione M., Corazza O., Deluca P., Davey Z., et al. Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother. Psychosom. 2011, 80:118-122.
8. Smith B., Higgins C., Baldacchino A., Kidd B., Bannister J. Substance misuse of gabapentin. Br. J. Gen. Pract. 2012, 62:406-407.
9. Bockbrader H.N., Wesche D., Miller R., Chapel S., Janiczek N., Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin. Pharmacokinet. 2010, 49:661-669.
10. Vuori E., Ojanperä I., Nokua J., Ojansivu R.L. Fatal poisonings in Finland during 2005-2007. Finnish Med. J. 2009, 64:3187-3195. (In Finnish; English summary).
11. Matuszewski B.K. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2006, 830:293-300.
12. Heikman P., Häkkinen M., Gergov M., Ojanperä I. Urine naloxone concentration at different phases of buprenorphine maintenance treatment. Drug Test Anal. 2014, 6:220-225.
13. Finnish Statistics on Medicines 2011 2012, Finnish Medicines Agency Fimea and Social Insurance Institution, Helsinki. A. Kalliokoski, J. Martikainen, T. Partio, L. Saastamoinen, T. Voipio (Eds.).
14. Grosshans M., Lemenager T., Vollmert C., Kämmerer N., Screiner R., Mutschler J., et al. Pregabalin abuse among opiate addicted patients. Eur. J. Clin. Pharmacol. 2013, 69:2021-2025.
15. Filipetto F.A., Zipp C.P., Coren J.S. Potential for pregabalin abuse or diversion after past drug-seeking behavior. J. Am. Osteopath. Assoc. 2010, 110:605-607.
16. Grosshans M., Mutschler J., Hermann D., Klein O., Dressing H., Kiefer F., et al. Pregabalin abuse, dependence, and withdrawal: a case report. Am. J. Psychiatry 2010, 167:869.
17. Gahr M., Franke B., Freudenmann R.W., Kölle M.A., Schönfeldt-Lecuona C. Concerns about pregabalin: further experience with its potential of causing addictive behaviors. J. Addict. Med. 2013, 7:147-149.
18. Blommel M.L., Blommel A.L., Pregabalin: An antiepileptic agent useful for neuropathic pain. Am. J. Health Syst. Pharm. 2007, 64:1475-1482.
19. Häkkinen M., Launiainen T., Vuori E., Ojanperä I. Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning. Eur. J. Clin. Pharmacol. 2012, 68:301-309.
20. Häkkinen M., Heikman P., Ojanperä I. Parenteral buprenorphine-naloxone abuse is a major cause of fatal buprenorphine-related poisoning. Forensic Sci. Int. 2013, 232:11-15.
21. Simonsen K.W., Normann P.T., Ceder G., Vuori E., Thordardottir S., Thelander G., et al. Fatal poisoning in drug addicts in the Nordic countries in 2007. Forensic Sci. Int. 2011, 207:170-176.
22. Berry D., Millington C. Analysis of pregabalin at the therapeutic concentrations in human plasma/serum by reversed-phase HPLC. Ther. Drug Monit. 2005, 27:451-456.
23. Wood D.M., Berry D.J., Glover G., Eastwood J., Dargan P.I. Significant pregabalin toxicity managed with supportive care alone. J. Med. Toxicol. 2010, 6:435-437.
24. Braga A.J., Chidley K. Self-poisoning with lamotrigine and pregabalin. Anaesthesia 2007, 62:524-527.
25. Miljevic C., Crnobaric C., Nikolic S., Lecic-Tosevski D. A case of pregabalin intoxication. Psychiatrike 2014, 23:162-165.
26. Schulz M., Iwersen-Bergmann S., Andresen H., Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics. Crit. Care 2012, 16:R136.
27. Middleton O. Suicide by gabapentin overdose. J. Forensic Sci. 2011, 56:1373-1375.
28. Moore K.A., Levine B., Fowler D. A fatality involving metaxalone. Forensic Sci. Int. 2005, 149:249-251.
29. Klein-Schwartz W., Shepherd J.G., Gorman S., Dahl B. Characterization of gabapentin overdose using a poison center case series. J. Toxicol. Clin. Toxicol. 2003, 41:11-15.
30. Onyeka I.N., Uosukainen H., Korhonen M.J., Beynon C., Bell J.S., Ronkainen K., et al. Sociodemographic characteristics and drug abuse patterns of treatment-seeking illicit drug abusers in Finland, 1997-2008: the Huuti study. J. Addict. Dis. 2012, 31:350-362.
31. Erdoǧan G., Ceyhan D., Güleç S. Possible heart failure associated with pregabalin use: case report. Agriculture 2011, 2:80-83.
32. Song H.K. Serotonin syndrome with perioperative oxycodone and pregabalin. Pain Physician 2013, 16:E632-E633.
33. Guglielmo R., Martinotti G., Clerici M., Janiri L. Pregabalin for alcohol dependence: a critical review of the literature. Adv. Ther. 2012, 29:947-957.